Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

被引:766
作者
Abi-Dargham, A
Rodenhiser, J
Printz, D
Zea-Ponce, Y
Gil, R
Kegeles, LS
Weiss, R
Cooper, TB
Mann, JJ
Van Heertum, RL
Gorman, JM
Laruelle, M
机构
[1] New York State Psychiat Inst & Hosp, Dept Neurosci, Div Brain Imaging, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA
[3] Columbia Univ Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA
关键词
D O I
10.1073/pnas.97.14.8104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The classical dopamine hypothesis of schizophrenia postulates a hyperactivity of dopaminergic transmission at the D-2 receptor. We measured in vivo occupancy of striatal D-2 receptors by dopamine in 18 untreated patients with schizophrenia and 18 matched controls, by comparing D-2 receptor availability before and during pharmacologically induced acute dopamine depletion. Acute depletion of intrasynaptic dopamine resulted in a larger increase in D-2 receptor availability in patients with schizophrenia (19% +/- 11%) compared with control subjects (9% +/- 7%, P = 0.003). The increased occupancy of D-2 receptors by dopamine occurred both in first-episode neuroleptic-naive patients and in previously treated chronic patients experiencing an episode of illness exacerbation. In addition, elevated synaptic dopamine was predictive of good treatment response of positive symptoms to antipsychotic drugs. This finding provides direct evidence of increased stimulation of D-2 receptors by dopamine in schizophrenia, consistent with increased phasic activity of dopaminergic neurons.
引用
收藏
页码:8104 / 8109
页数:6
相关论文
共 56 条
[1]  
Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761
[2]   WORKSHOP ON SCHIZOPHRENIA, PET, AND DOPAMINE D2 RECEPTORS IN THE HUMAN NEOSTRIATUM [J].
ANDREASEN, NC ;
CARSON, R ;
DIKSIC, M ;
EVANS, A ;
FARDE, L ;
GJEDDE, A ;
HAKIM, A ;
LAL, S ;
NAIR, N ;
SEDVALL, G ;
TUNE, L ;
WONG, D .
SCHIZOPHRENIA BULLETIN, 1988, 14 (03) :471-484
[3]  
ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789
[4]   Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method [J].
Breier, A ;
Su, TP ;
Saunders, R ;
Carson, RE ;
Kolachana, BS ;
de Bartolomeis, A ;
Weinberger, DR ;
Weisenfeld, N ;
Malhotra, AK ;
Eckelman, WC ;
Pickar, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2569-2574
[5]  
BRODIE HKH, 1971, CLIN PHARMACOL THER, V12, P218
[6]   Epidemiology and natural history of schizophrenia [J].
Bromet, EJ ;
Fennig, S .
BIOLOGICAL PSYCHIATRY, 1999, 46 (07) :871-881
[7]   INVITRO BINDING-PROPERTIES AND AUTORADIOGRAPHIC IMAGING OF 3-IODOBENZAMIDE ([I-125] IBZM) - A POTENTIAL IMAGING LIGAND FOR D-2 DOPAMINE-RECEPTORS IN SPECT [J].
BRUCKE, T ;
TSAI, YF ;
MCLELLAN, C ;
SINGHANYOM, W ;
KUNG, HF ;
COHEN, RM ;
CHIUEH, CC .
LIFE SCIENCES, 1988, 42 (21) :2097-2104
[8]   THE CURRENT STATUS OF THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA [J].
CARLSSON, A .
NEUROPSYCHOPHARMACOLOGY, 1988, 1 (03) :179-186
[9]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483
[10]   Presynaptic dopaminergic function in the striatum of schizophrenic patients [J].
DaoCastellana, MH ;
PaillereMartinot, ML ;
Hantraye, P ;
AttarLevy, D ;
Remy, P ;
Crouzel, C ;
Artiges, E ;
Feline, A ;
Syrota, A ;
Martinot, JL .
SCHIZOPHRENIA RESEARCH, 1997, 23 (02) :167-174